NICOLE CINCINNATI: Open Payments
NPI 1952367237 · WYOMISSING, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,814 in 107 payments from 25 companies in 2025. Trend: 2023 $2,228 · 2024 $2,306 · 2025 $2,814
Food & beverage: $2,414Speaker / faculty: $400
| Company | Payments | Amount |
|---|---|---|
| Senseonics, Incorporated | 1 | $400 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 14 | $323 |
| Calliditas Therapeutics US Inc. | 8 | $241 |
| ABBVIE INC. | 8 | $204 |
| Novo Nordisk Inc | 9 | $195 |
| Ardelyx, Inc. | 5 | $180 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $174 |
| AstraZeneca Pharmaceuticals LP | 9 | $153 |
| Fresenius USA Marketing, Inc. | 7 | $139 |
| SCPHARMACEUTICALS INC. | 2 | $128 |
Products named: Eversense, JARDIANCE, TARPEYO, Kerendia, VELPHORO, LOKELMA, FUROSCIX, XPHOZAH 30 MG.
Industry payments across PA — which companies pay providers there.
